DLL4+ dendritic cells: Key regulators of Notch Signaling in effector T cell responses

作者：Meng, Lijun; Hu, Shaoyan; Wang, Jian; He, Shan; Zhang, Yi^*

来源：Pharmacological Research, 2016, 113: 449-457.

DOI：10.1016/j.phrs.2016.09.001

• DLL4
• DLL4(+) DCs
• Notch signaling
• Tumor immunity
• Alloimmunity and autoimmunity

Dendritic cells (DCs) are critical regulators of adaptive immune responses. DCs can elicit primary T cell responses at low DC:T cell ratios through their expression of high levels of antigen -presenting molecules and costimulatory molecules. DCs are important for induction of functionally diverse T cell subsets such as CD4(+) T helper (Th)1 and Th17 cells and effector CD8(+) T cells able to reside in epithelial tissues. Recent studies begin illuminating the underlying mechanism by which DCs regulate specialized T cell subsets. DCs are composed of subsets that differ in their phenotype, localization and function. DCs expressing high levels of DLL4 (DLL4(+) DCs), which is a member of Notch ligand family, are newly discovered cells that have greater ability than DLL4(-) DCs to promote the generation of Thl and Th17 CD4(+) T cells. DLL4 derived from DLL4(+) DCs is also important for promoting the differentiation and expansion of effector CDS' T cells. Experimental studies have demonstrated that selective deletion of DLL4 in DCs causes impaired antitumor immunity. In contrast, blocking DLL4 leads to dramatic reduction of inflammatory T cell responses and their -mediated tissue damage. We will discuss emerging functional specialization within the DLL4(+) DC compartment, DLL4(+) DC biology and the impact of pharmacological modulation of DLL4 to control inflammatory disorders. 2016 Elsevier Ltd.

• 出版日期2016-11
• 单位苏州大学